Your weekly roundup of STAT's First Opinion

Expert opinion and perspective, curated by Patrick Skerrett ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

The First Opinion Podcast returns to its weekly schedule on Wednesday. If you're a podcast fan, or new to this medium, please check it out. And you can catch up with the week's crop of First Opinion essays here. Commissioner Califf needs to put the F back in FDA By Bill Frist and Jerome M. Adams and Jerold Mande Matt Rourke/AP With the nation in a nutrition crisis, Commissioner Califf needs to harness the FDA's effective but underused food-related regulatory powers. Read More Biden administration (finally) elevates healthy buildings as part of national Covid strategy By Joseph G. Allen Mark Lennihan/AP The White House has announced it is elevating ventilation and "clean air in buildings" as a key pillar in the national Covid-19 response. Read More If pharma can market to youths by TikTok, it should include them in clinical trials By Sneha Dave Adobe Research isn't complete unless it includes adolescents and young adults who end up taking the medications being tested. Read More Sponsor content by STAT+ Biopharma breakthroughs, business, and policy analysis ⁠— at your fingertips Enjoy daily, market-moving analysis of the biotech, pharma, and life sciences industries with STAT Plus. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. Don't be the last to know. Subscribe today to start reading. Listen: The 'underground market' for insulin and diabetes supplies By Patrick Skerrett This week on "The First Opinion Podcast," diabetes advocate Alina Bills talks about insulin's high cost and social media efforts to help. Read More Health-related artificial intelligence needs rigorous evaluation and guardrails By John D. Halamka and Suchi Saria and Nigam H. Shah Standards, guardrails, and guidance are needed to enhance the reliability of clinical AI tools and earn public confidence in them. Read More Emergency response systems must not overlook people with substance use disorders By Emma Biegacki YUKI IWAMURA/AFP via Getty Images Emergency response programs often fail to consider the needs of people with opioid and other substance use disorders. Read More Welcome back, Dr. Califf: Patients will see you now By Anthony Yanni Adobe Biopharma companies need to include patients in decision-making on every step of drug development, something Robert Califf supports. Read More Covid-19 and telehealth: Holding on to the gains of remote care By Kevin Riddleberger Adobe Telehealth and remote care earned their stripes during the pandemic. Their utility during "normal times" could be limitless. Read More Applied neuroscience needs a task force to craft effective governance By David Beier and Lucy Nalbach Tournas and Gary Marchant Adobe Appropriate guardrails must be put in place for applied neuroscience now to prevent unethical or unsafe applications of the technology. Read More Sunday, March 20, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser